Session Keynote Speakers

Dr. Mark Allenby, Queensland University of Technology (QUT)

Dr Mark C Allenby is a Lecturer and Advance Queensland research fellow at Queensland University of Technology coupling tissue systems models and bioimage analyses to engineer improved medical treatments using experimental and computational approaches. Allenby is an investigator in the Herston Biofabrication Institute at the Royal Brisbane & Women's Hospital in Australia. URL: https://staff.qut.edu.au/staff/mark.allenby.

Prof. Joaquim Cabral, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, University of Lisbon, Portugal

Joaquim Cabral is a Distinguished Professor of Instituto Superior Técnico, University of Lisbon, Portugal. He was the Founding Head of Department of Bioengineering and Founding Director of the Institute for Bioengineering and Biosciences. He is graduated in Chemical Engineering with a PhD and “Habilitation” degrees in Biochemical Engineering in 1983 and 1988, respectively. He was a post-doctoral fellow at Massachusetts Institute of Technology (1983-1984). He joined IST faculty as Assistant Professor in 1984 and became Associate Professor in 1987 and Full Professor of Chemical and Biological Engineering in 1992. He has authored more than 580 publications (WoS h index 55).

Prof. dr. Antonio Campos, Departmen of Histolgy, School of Medicine University of Granada, Spain

Antonio Campos is Full Professor of Histology at the University of Granada. He has been president of the Spanish Society of Histology, Dean and director of the National Institute of Health Carlos III where he promoted new models of biomedical investigation programs.  Promoter of tissue engineering, his group has created artificial tissues that have already been transferred to the clinic.  He has published relevant books and papers in high impact factor journals related to tissue engineering and Medical Education. Member of the Spanish Royal Academy of Medicine he has received three honoris causa doctorates in Argentina, Dominican Republic and Portugal.

Prof. Dr. Laura De Laporte, DWI - Leibniz Institute for Interactive Materials

Laura De Laporte designs Advanced Biomedical Systems that direct the interaction with cells. She studied Chemical Engineering in Ghent, where she got the tissue engineering microbe. During her PhD at Northwestern University, she engineered guiding implants for nerve regeneration, while her postdoc at EPFL in Jeffrey Hubbell’s group focused on smart hydrogels. Currently, she is a Leibniz Professor at the RWTH University and DWI-Leibniz Institute for Interactive Materials (Aachen, Germany). In her ERC Starting Grant Anisogel, her team designs low-invasive, polymeric hydrogel therapies that orient after injection to repair anisotropic tissues. In addition, dynamic hydrogels are created to study mechanobiology.

Dr. David Dean, The Ohio State University

In 1993 David Dean’s PhD thesis presented a template-based method for producing average 3D organ surface images. As a postdoctoral researcher at New York University he used average skull images as targets for surgical simulation and intra-operative guidance. Later at Case Western Reserve University he was the first person to use average surfaces to design and 3D print patient-specific cranial implants. His regenerative medicine research incorporates skeletal progenitor cells and 3D printing resorbable biomaterials. Since 2013 his research at The Ohio State University has included 3D printed NiTi for stiffness-matched skeletal fixation devices and Mg alloys for resorbable skeletal devices.

Prof. Jinah Jang, Pohang University of Science and Technology

Dr. Jinah Jang received her PhD at Pohang University of Science and Technology (POSTECH) in Korea, and trained as postdoctoral fellow in POSTECH and Institute for Stem Cell and Regenerative Medicine at University of Washington. She has joined the POSTECH in 2017 as an assistant professor in the Creative IT Engineering, Mechanical Engineering, and School of Interdisciplinary Bioscience and Bioengineering. She has published 57 peer-reviewed articles in journals including Science Advances, Nature Communications, and Biomaterials (H-index: 24). Her research interest lies in engineering the functional human tissues using high-performance stem cells and printable biomaterials via the 3D bioprinting technology.

Prof. Julian Jones, Imperial College London

Julian Jones leads a research group on bioactive glasses and hybrids, particularly 3D scaffolds and therapeutic nanoparticles. He has >130 articles and 4 patent applications and has co-edited three biomaterials text books. He was elevated to Fellow of the Society for Glass Technology in 2018, Fellow of the American Ceramics Society in 2015; was awarded an ISCM (International Society for Ceramics in Medicine) Excellence Award in 2016; the 2014 Vittorio Gottardi Award from the International Commission on Glass (ICG). He is Chair-elect of the Bioceramics Division of the American Ceramics Society and Editor of the RSC Biomaterials Science Book Series.

Prof. David Kaplan, Tufts University

David Kaplan is the Stern Family Endowed Professor of Engineering at Tufts University, Distinguished University Professor, and Professor and Chair of the Department of Biomedical Engineering. His research focus is on biopolymer engineering to understand structure-function relationships and on tissue engineering and regenerative medicine. His lab has published over 900 peer reviewed papers, he is the editor-in-chief of ACS Biomaterials Science and Engineering, and he serves on many editorial boards and programs for journals and universities, and has received a number of awards for teaching and research.

Prof. Dr. Masahiro Kino-oka, Department of Biotechnology, Osaka University

Masa (Masahiro KINO-OKA) is one of leaders in the field of cell manufacturing, who contributes to the standardization of the cell processing facility and manufacturing. His current research interests are “Bioprocess engineering” to establish the cell and tissue manufacturing system. Toward the current professional status, Masa earned the Ph.D. (chemical engineering) in 1996, and he spent one year as a visiting staff in the Department of Chemical Engineering, National Institute of Switzerland (ETH) in Zurich. After returning, he promoted twice in his five-year tenure, and he earned a current position of Professor in Biotechnology, Osaka University since 2009.

Prof. Sean Palecek, University of Wisconsin - Madison

Prof. Sean Palecek is the Milton J. and Maude Shoemaker Professor of Chemical and Biological Engineering at the University of Wisconsin – Madison, the Director for Research for the National Center for Cell Manufacturing Technologies, and Director for Research Innovation of the Forward BIO Institute. Prof. Palecek’s research group develops processes for biomanufacturing of cells and tissues from human pluripotent stem cells, with a current focus on cardiovascular and neurovascular lineages. They strive to engineer robust, scalable platforms to produce high quality cells and tissues for in vitro diagnostics as well as regenerative medicine applications.

Dr. Qasim Rafiq, University College London

Dr Qasim Rafiq is an Associate Professor at University College London in Cell and Gene Therapy Bioprocessing. He is a multidisciplinary engineer and currently leads a research portfolio of >£3.5m and heads up the ATMP Bioprocess Engineering group which includes 4 PDRAs and 12 PhD students. He is the Programme Director of a new MSc programme in the Manufacture and Commercialisation of Stem Cell and Gene Therapies. He is both a Chartered Engineer (CEng) and Chartered Scientist (CSci) and sits on multiple scientific and engineering committees including the BIA’s Cell and Gene Therapy Advisory Committee and BSI’s Biotechnology Standards Group.

Prof. Dr. Dimitrios Stamatialis, University of Twente

Prof. Dr. Dimitrios Stamatialis obtained his PhD at NRC “Demokritos” (Athens - Greece) in 1995 in the field of physical chemistry and membranes. He is full professor of (bio)artificial organs at the University of Twente in the Netherlands.
Prof. Stamatialis has been involved in numerous projects leading to products and applications, some licensed to companies. He is author of more than 145 scientific papers and inventor of 9 patents. He has various international activities, including: Chairman of the working group on bioartificial organs of the European Society of artificial organs (ESAO) and editor of the “international journal of artificial organs”.

Prof. Dr. Yasuhiko Tabata, Institute for Frontier Life and Medical Sciences, Kyoto University

Dr. Yasuhiko Tabata is the Professor of Institute for Frontier Life and Medical Sciences, Kyoto University and guest professors of 17 different universities. He received his BD in Polymer Chemistry (1981), Ph.D. (1988) in Technology, D.Med.Sc. (2002), and D.Pharm. (2003) all at Kyoto University. He was a Visiting Scientist at the MIT (Professor Robert Langer) (1991-92). He has published 1,630 scientific papers including 145 book chapters and review articles, and has 130 patents. He received the Scientific Award from the Japanese Society for Biomaterials (2002), the Japan Society of Drug Delivery System (2011), TERMIS-AP (2018), and 5 other scientific awards.

Prof. Pierre vanderhaeghen, VIB Belgium

Pierre Vanderhaeghen is Professor at the VIB Center for Brain and Disease Research at KU Leuven, and Université Libre de Bruxelles, Belgium. His research is focused the mechanisms of development of the cerebral cortex in direct link with human brain evolution and diseases. His lab uses classical tools such as mouse genetics and embryology, as well as innovative models of corticogenesis from pluripotent stem cells, which were pioneered in his lab.

Dr. Joaquim Vives, Banc de Sang i Teixits

I am a Biochemist with extensive experience in the R&D biotech sector, both in private and academic environments. I focused my career on the optimisation of cellular processes towards A) high yield production of diagnostic and therapeutic molecules, and B) the development of methods to produce cells for drug screening and therapy, in compliance with current regulatory and quality standards. Apart from leading MTA production for clinical trials, I focus my research in A) the generation of 3D tissue engineering products, B) the development of animal models for the study of tissue regeneration and identification of biomarkers of tissue remodelling.

Dr. Yoram Vodovotz, University of Pittsburgh

Dr. Yoram Vodovotz is currently a Professor of Surgery, Immunology, Computational and Systems Biology, Bioengineering, Clinical and Translational Science, and Communication Science and Disorders at the University of Pittsburgh School of Medicine. His research focus is the systems biology of inflammation. He is the Director of the Center for Inflammation and Regeneration Modeling (CIRM; http://www.mirm.pitt.edu/our-research/centers/center-for-inflammation-an...) at the McGowan Institute for Regenerative Medicine, a co-founder and past President of the Society for Complex Acute Illness (www.scai-med.org), and a co-founder of Immunetrics, Inc. (www.immunetrics.com), a Pittsburgh-based company that is commercializing this mathematical modeling work. He has published over 300 manuscripts.

Prof. Slobodan Vukicevic, Laboratory for Mineralized Tissues, Center for Translational and Clinical Research, University of Zagreb School of Medicine

Slobodan Vukicevic is a full professor and head of Laboratory of Mineralized Tissues, Center for Translational and Clinical Research, University of Zagreb School of Medicine. He is a full member of the Croatian Academy of Sciences and Arts. His scientific interests comprise bone and cartilage morphogenetic proteins and development of drugs for regeneration of bone, kidney and heart muscle. Inventor of more than 30 patents and editor of 4 books on BMPs. Founder of Genera Research, innovation-based biotechnology company developing a novel regenerative therapy for bone defects via coordinating collaborative programs OSTEOGROW (FP7) and OSTEOproSPINE (HORIZON 2020).

Prof. Matthew Webber, University of Notre Dame

Assistant Professor of Chemical & Biomolecular Engineering, University of Notre Dame, USA.

Prof. Dr. Regine Willumeit-Römer, Helmholtz Zentrum Geesthacht, Metallische Biomaterialien

R. Willumeit-Römer studied and obtained a PhD in physics by working on the structure of ribosomes. Habilitation and venia legendi in biochemistry. After working on peptide antibiotics and antimicrobial implant surfaces focus on degradable Mg-based implants. Current position: Director of the Institute for Materials Research, Divison Metallic Biomaterials, Helmholtz-Center Geesthacht and Professor at the Faculty of Engineering, Christian-Albrechts-University, Kiel, Germany.      

Prof. Dr. Tobias Winkler, Universitätsmedizin Berlin / Regenerative Orthopädie und Unfallchirurgie

Prof. Dr. Tobias Winkler is orthopedic and trauma surgeon at the Center for Muskuloskeletal Surgery (CMSC) of the Charité Berlin. He is coordinator of an international research consortium performing the worldwide only phase III trial of an allogeneic cell therapy for regeneration after skeletal muscle injury. He is head of a research team, which main focus is the translation of advanced therapies for musculoskeletal indications. His research work in the field encompasses cell therapies with adult mesenchymal and blood cells for bone tendon and muscle regeneration and the development of biomaterials for bone regeneration.